Literature DB >> 17705753

Effects of proximal and distal ends of double-J ureteral stent position on postprocedural symptoms and quality of life: a randomized clinical trial.

Ahmed M Al-Kandari1, Tariq F Al-Shaiji, Hani Shaaban, Hamdy M Ibrahim, Yehya H Elshebiny, Ahmed A Shokeir.   

Abstract

PURPOSE: To evaluate the effect of the position of the proximal and distal ends of Double-J ureteral stents on postprocedural flank pain, lower urinary-tract symptoms, and quality of life. PATIENTS AND METHODS: The study included 120 patients who required unilateral Double-J ureteral stents for various indications. They were randomized into two equal groups. Group 1 had longer stents, with the proximal end in the upper calix and the distal end crossing the midline of the bladder. Group 2 had proper stent length with the proximal end in the pelvis and the lower end just beyond the vesicoureteral junction. Patients answered a questionnaire regarding flank pain, dysuria, and urgency as well as quality of life after 1 week of stenting.
RESULTS: Forty patients (67%) of group 1 and 43 (72%) of group 2 had mild flank pain, especially during urination. There was no significant difference in the degree of flank pain in the two groups. Moderate to severe dysuria was reported by 53 patients (88%) in group 1 and 11 patients (18%) in group 2 (P < 0.001). Moderate to severe urgency was reported by 48 patients (80%) in group 1 and in 14 (23%) in group 2 (P < 0.001). A worse quality of life was reported by patients in group 1, among whom moderate to severe bother was noted by 51 (85%) compared with group 2, in which moderate to severe bother was reported by only 13 patients (22%) (P < 0.001).
CONCLUSION: Ureteral stents are associated with flank pain and lower urinary-tract symptoms. The flank pain was not affected by the length of stent. Urgency and dysuria as well as a worse quality of life were significantly more common in the patients who had longer stents.

Entities:  

Mesh:

Year:  2007        PMID: 17705753     DOI: 10.1089/end.2007.9949

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  24 in total

Review 1.  Current status of ureteral stent technologies: comfort and antimicrobial resistance.

Authors:  Carlos E Mendez-Probst; Alfonso Fernandez; John D Denstedt
Journal:  Curr Urol Rep       Date:  2010-03       Impact factor: 3.092

Review 2.  Ureteral stent-associated complications--where we are and where we are going.

Authors:  Dirk Lange; Samir Bidnur; Nathan Hoag; Ben H Chew
Journal:  Nat Rev Urol       Date:  2014-12-23       Impact factor: 14.432

3.  Size does matter: ureteral stents with a smaller diameter show advantages regarding urinary symptoms, pain levels and general health.

Authors:  Sebastian Nestler; B Witte; L Schilchegger; J Jones
Journal:  World J Urol       Date:  2019-05-31       Impact factor: 4.226

4.  [Uretero(reno)scopy: management of complications].

Authors:  T Knoll; G Wendt-Nordahl
Journal:  Urologe A       Date:  2014-05       Impact factor: 0.639

5.  Randomized, double-blind, placebo-controlled trial to compare solifenacin versus trospium chloride in the relief of double-J stent-related symptoms.

Authors:  Mohamed H Abdelhamid; Ahmed S Zayed; Waleed E Ghoneima; Akrm A Elmarakbi; Mohamed S El Sheemy; Ahmed Aref; Ahmed Abdelbary; Hani H Nour
Journal:  World J Urol       Date:  2017-01-03       Impact factor: 4.226

6.  Stent Position Is More Important than α-Blockers or Anticholinergics for Stent-Related Lower Urinary Tract Symptoms after Ureteroscopic Ureterolithotomy: A Prospective Randomized Study.

Authors:  Sun Ju Lee; Changhee Yoo; Cheol Young Oh; Yong Seong Lee; Sung Tae Cho; Seong Ho Lee; Dae Yul Yang; Sang Kon Lee; Jin Seon Cho
Journal:  Korean J Urol       Date:  2010-09-16

7.  Preoperative Belladonna and Opium Suppository for Ureteral Stent Pain: A Randomized, Double-blinded, Placebo-controlled Study.

Authors:  Franklin C Lee; Sarah K Holt; Ryan S Hsi; Brandon M Haynes; Jonathan D Harper
Journal:  Urology       Date:  2016-09-19       Impact factor: 2.649

8.  A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms.

Authors:  Ahmed R El-Nahas; Mohamed Tharwat; Mohamed Elsaadany; Ahmed Mosbah; Mohamed A Gaballah
Journal:  World J Urol       Date:  2015-10-09       Impact factor: 4.226

Review 9.  Ureteral Stent Discomfort and Its Management.

Authors:  Katherine M Fischer; Michael Louie; Phillip Mucksavage
Journal:  Curr Urol Rep       Date:  2018-06-11       Impact factor: 3.092

10.  Ureteral stent discomfort: Etiology and management.

Authors:  Ricardo Miyaoka; Manoj Monga
Journal:  Indian J Urol       Date:  2009 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.